We bring a broad range of skills and experience to Ultragenyx, including genetic counseling, nursing, clinical trial coordination and commercialization of medications. Our background helps us understand and address the diverse needs of people affected by rare diseases.
Jessica Riviere, MHS
Vice President, Global Patient Advocacy and Patient Engagement
In the 1990s, I learned firsthand about the power of community engagement to bring about positive change when I worked for U.S. Senator Edward Kennedy on healthcare reform. Since then, I have had the privilege to work with diverse patient communities across chronic and rare diseases. I am humbled by the power and determination of patient communities to champion their unique and universal needs; access to innovative medicines and care, the development of therapies that meet the needs and preferences of patients and building a world where people see them beyond the disease with which they live. My goal is to help ensure that the needs of patients and their families are heard and valued.
Executive Director, EU Patient Advocacy
I recognize that the journey of medicine from initial research to patient access is not an easy one, and I hope that my 20 years of industry and non-governmental organizational (NGO) experience may help shed light on a process that brings hope, but also responsibility, to all involved.
I believe that those living with rare diseases and those representing them are the best posed to advise on what it means to live with a rare condition. Integrating the patient- and family-perspective into the drug development process results in better outcomes for everyone including patients, family members, organizations, and society. I am proud to work with the European patient advocacy community on behalf of Ultragenyx; I strive to ensure that, as a company, we truly understand this community’s needs and that we develop program that reflect the reality of people’s lived experiences across geographies.
Senior Director, Patient Advocacy
Every patient has a story, but not every patient has a voice. Throughout my career, I have been touched by the powerful stories of patients and care partners sharing their most intimate and heartfelt stories. Giving patients the opportunity to be heard and share their insights and inspiring stories has been the central focus of my work as a journalist, communications professional, and patient advocate. People living with rare diseases face even greater hurdles finding their voices, connecting with others, and getting the right information. My hope is that these stories will inspire others to speak boldly, get more involved in rare disease communities, and be a reminder that there are many individuals and patient advocacy groups ready to help.
Jenny McCue, MHP
Senior Director, Patient Advocacy
I participated in my first clinical trial when I was nine years old and know firsthand the power of the patient. With a deep belief that true change comes from patient-centered partnerships, I have built a career crafting engagement campaigns and implementing strategies to effectively partner with patients, advocates, physicians, regulators and policymakers. I have worked within the federal government, nonprofits, and industry to develop and deploy impactful patient advocacy strategies on a global level with a focus on rare diseases.
Director, Patient Advocacy
As the mother of four, including a set of triplets, I’ve navigated many challenging situations. However, when one of my sons was diagnosed with an ultra-rare and life-threatening genetic disorder, our lives were turned upside down. It was critical that I become educated about my son’s diagnosis and learn how to advocate for his health and treatment. As my son’s condition stabilized, I made the decision to change careers. I have been honored to give back to the rare disease community by working in the biopharmaceutical industry as a patient advocate over the last decade. Many of the lessons our family learned along the way were not easy and my hope is to share this hard-earned knowledge in an effort to make someone else’s journey just a little easier.
Kristin Voorhees, MA
Director, Patient Advocacy
My passion for creating change within the healthcare system began with my own experience of enduring years of misdiagnoses and ill health before receiving an accurate diagnosis. I quickly realized the important role that educated and empowered patients and care partners play in the healthcare setting. I began a career in health communication to help people understand how to actively participate in their own diagnosis, disease management and treatment journeys. I’ve been privileged to collaborate with and alongside patients, families, clinicians and researchers on developing educational programs that accelerate diagnoses, improve patients’ daily lives and advance research. This work led to my current role at Ultragenyx, where I am excited to support and advocate for the rare disease community. My daily goals are to make a positive difference in the lives of patients, care partners and families and ensure that their voices are heard.
Belen Gonzalez Sutil, MA
Associate Director, LATAM Patient Advocacy
After earning my master’s degree in nonprofit leadership and management and exploring different areas of the nonprofit world in Argentina and the United States, I found that my true passion is helping those whose voices are not always heard—patients and families affected by rare disease. For the past few years, I have been helping patients understand how to proactively participate in their diagnoses, how to manage their diseases, and how to explore treatment options. At Ultragenyx, I am eager to help and advocate for those living with rare diseases around Latin America. My daily goal is to better serve those in need so they can have a better quality of life.
Senior Manager, Patient Advocacy
Throughout my life, I’ve had a heart for those in need. From volunteering for animal welfare, participating in local events to support The March of Dimes or rare diseases like spinal muscular atrophy (SMA), and most importantly, adopting my amazing son. With a background in pharmaceuticals, I quickly realized my soul’s purpose is working with and advocating for individuals and families affected by rare disease, which has happily led me to Ultragenyx. In this role, I can see firsthand how empowering, informing, and amplifying the voices of those living with rare diseases can make a difference. Knowing that there are people out there who need support keeps me motivated every day to do more.
Patient Advocacy Specialist
My first advocacy experience was testifying on Capitol Hill, and I felt the power of using my voice for the rare disease community. I chose to become an advocate to create a positive change in the lives of others. My goal is to help those living with rare diseases with issues that affect them and help make their voices heard. I was born with a rare disease known as MPSVI, and I had the privilege to participate in clinical trials where the study drug was approved by the FDA. I know that raising awareness about rare diseases improves the chances of being understood and brings attention to therapies and treatments. I graduated with honors from CSUEB in 2018 with a B.A. degree in Sociology. As an intern for Assembly member Rob Bonta, who led the Rare Disease California Caucus, I learned more about legislation that affects the rare disease community and wrote a proposal for a bill to support patients with MPSVI. At Ultragenyx, I will continue to be a strong voice for the community.
LATAM Patient Advocacy Specialist
If you are willing to commit, there is room for you. So I did. I committed. I put my heart into it. For the last 10 years, I have worked at patient associations and rare disease non-profit organizations in LATAM and the United States, supporting groups efforts to grow as communities, getting involved in research to advance treatment development and advocating for health equity access to adequate care. In the rare disease community, I found my mission: to advocate in partnership for a better life for patients and their families. I learned how to be a better listener and partner, how to support and how to step up. I learned about resilience and love. I am truly excited about this new chapter at Ultragenyx, where I will continue supporting patient groups and advocating with a strong commitment to the rare disease community.